Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma
Open Access
- 16 January 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (3), 345-350
- https://doi.org/10.1038/modpathol.2008.197
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutationsGynecologic Oncology, 2008
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer PreventionJournal of Clinical Oncology, 2008
- Histologic and immunohistochemical decision-making in endometrial adenocarcinomaLaboratory Investigation, 2008
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutationsGynecologic Oncology, 2008
- Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous CarcinomaClinical Cancer Research, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancersDiagnostic Pathology, 2008
- A candidate precursor to serous carcinoma that originates in the distal fallopian tubeThe Journal of Pathology, 2006
- Chromatin in Need of a Fix: Phosphorylation of H2AX Connects Chromatin to DNA RepairMolecular Cell, 2005
- Endometrial Glandular Dysplasia: A Putative Precursor Lesion of Uterine Papillary Serous Carcinoma. Part II: Molecular FeaturesInternational Journal of Surgical Pathology, 2004